{"DataElement":{"publicId":"3119315","version":"1","preferredName":"Melanoma Pathological T Stage","preferredDefinition":"Code to represent the extent of melanoma in the primary tumor site based on staging guidelines from the AJCC edition 7.0.","longName":"2192180v1.0:3119301v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2192180","version":"1","preferredName":"Melanoma Tumor Pathologic T Stage","preferredDefinition":"information related to pathologic T stage for a melanoma tumor.","longName":"MELANOMA_TUMOR_P_T","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206800","version":"1","preferredName":"Melanoma Neoplasm","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3224:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-04EC-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9010B70-BFF4-1148-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3119301","version":"1","preferredName":"Melanoma Pathological T Stage","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004_An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens.  Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3119301v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Melanoma >4.0 mm with ulceration","ValueMeaning":{"publicId":"3119302","version":"1","preferredName":"Melanoma >4.0 mm with ulceration","longName":"3119302","preferredDefinition":"Melanoma >4.0 mm with ulceration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8760-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8779-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Melanoma >4.0 mm without ulceration","ValueMeaning":{"publicId":"3119303","version":"1","preferredName":"Melanoma >4.0 mm without ulceration","longName":"3119303","preferredDefinition":"Melanoma >4.0 mm without ulceration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8783-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-879C-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T4","valueDescription":"Melanoma >4.0 mm","ValueMeaning":{"publicId":"3119304","version":"1","preferredName":"Melanoma >4.0 mm","longName":"3119304","preferredDefinition":"Melanoma >4.0 mm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-87A6-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-87BF-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Melanoma 2.01 - 4.0 mm with ulceration","ValueMeaning":{"publicId":"3119305","version":"1","preferredName":"Melanoma 2.01 - 4.0 mm with ulceration","longName":"3119305","preferredDefinition":"Melanoma 2.01 - 4.0 mm with ulceration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-87C9-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-87E2-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Melanoma 2.01 - 4.0 mm without ulceration","ValueMeaning":{"publicId":"3119306","version":"1","preferredName":"Melanoma 2.01 - 4.0 mm without ulceration","longName":"3119306","preferredDefinition":"Melanoma 2.01 - 4.0 mm without ulceration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-87EC-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8805-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T3","valueDescription":"Melanoma 2.01 - 4.0 mm","ValueMeaning":{"publicId":"3119307","version":"1","preferredName":"Melanoma 2.01 - 4.0 mm","longName":"3119307","preferredDefinition":"Melanoma 2.01 - 4.0 mm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-880F-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8828-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T2b","valueDescription":"Melanoma 1.01 - 2.0 mm with ulceration","ValueMeaning":{"publicId":"3119308","version":"1","preferredName":"Melanoma 1.01 - 2.0 mm with ulceration","longName":"3119308","preferredDefinition":"Melanoma 1.01 - 2.0 mm with ulceration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8832-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-884B-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T2a","valueDescription":"Melanoma 1.01 - 2.0 mm without ulceration","ValueMeaning":{"publicId":"3119309","version":"1","preferredName":"Melanoma 1.01 - 2.0 mm without ulceration","longName":"3119309","preferredDefinition":"Melanoma 1.01 - 2.0 mm without ulceration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8855-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-886E-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T2","valueDescription":"Melanoma 1.01 - 2.0 mm","ValueMeaning":{"publicId":"3119310","version":"1","preferredName":"Melanoma 1.01 - 2.0 mm","longName":"3119310","preferredDefinition":"Melanoma 1.01 - 2.0 mm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8878-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8891-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Melanoma <= 1.0 mm in thickness with ulceration or mitoses >=1/mm2","ValueMeaning":{"publicId":"3119311","version":"1","preferredName":"Melanoma <= 1.0 mm in thickness with ulceration or mitoses >=1/mm2","longName":"3119311","preferredDefinition":"Melanoma <= 1.0 mm in thickness with ulceration or mitoses >=1/mm2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-889B-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-88B4-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Melanoma <= 1.0 mm in thickness without ulceration and mitosis <1/mm2","ValueMeaning":{"publicId":"3119312","version":"1","preferredName":"Melanoma <= 1.0 mm in thickness without ulceration and mitosis <1/mm2","longName":"3119312","preferredDefinition":"Melanoma <= 1.0 mm in thickness without ulceration and mitosis <1/mm2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-88BE-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-88D7-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T1","valueDescription":"Melanoma <= 1.0 mm in thickness","ValueMeaning":{"publicId":"3119313","version":"1","preferredName":"Melanoma <= 1.0 mm in thickness","longName":"3119313","preferredDefinition":"Melanoma <= 1.0 mm in thickness","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-88E1-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-88FA-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Melanoma In Situ","ValueMeaning":{"publicId":"2577199","version":"1","preferredName":"Melanoma In Situ","longName":"2577199","preferredDefinition":"Melanoma In Situ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma In Situ","conceptCode":"C4224","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA9C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"SBREXT","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-890E-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"T0","valueDescription":"T0 Stage Finding","ValueMeaning":{"publicId":"2580826","version":"1","preferredName":"T0 Stage Finding","longName":"2580826","preferredDefinition":"No evidence of primary tumor, in accordance with TNM classification system guidelines. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T0 TNM Finding","conceptCode":"C48719","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8919-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"TX","valueDescription":"TX Stage Finding","ValueMeaning":{"publicId":"2580827","version":"1","preferredName":"TX Stage Finding","longName":"2580827","preferredDefinition":"Status of the primary tumor cannot be assessed in accordance with TNM classification system guidelines. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08C8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8923-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3119300","version":"1","preferredName":"Melanoma Pathological Staging T Stage Stage","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens.  Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3224:C28257:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathological Staging","conceptCode":"C28257","definition":"An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens. Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8739-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-874A-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"REEVESD","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic Stage: Primary Tum","type":"Preferred Question Text","description":"Pathologic Stage: Primary Tumor (T)","url":null,"context":"NCIP"},{"name":"TCGA Comment","type":"COMMENT","description":"Values of 'Not Otherwise Specified' or 'NOS' may be included in stage values.","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-894E-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 7/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}